CDKN2A and Miyoshi myopathy: In MM and other cancers the promoters of many tumor suppressors including p21CIP1, p15INK4B, p16INK4A and apoptosis inducers are hypermethylated during transformation from monoclonal gammopathy of unknown significance (MGUS) to symptomatic MM [13].